文献速递艾滋病与性传播感染

HIV感染巨噬细胞产生的新型不可抑制性病毒血症

A New Type of Nonsuppressible Viremia Produced by HIV-Infected Macrophage.
PubMed 文献 · J Infect Dis · 2026-01-01

该研究分析了4例接受抗逆转录病毒治疗(ART)后出现原发性不可抑制性病毒血症(NSV)的晚期免疫缺陷患者。结果显示,ART虽停止病毒复制,但长寿的HIV感染巨噬细胞持续产生病毒,这与CD4+ T细胞克隆引起的继发性NSV机制不同,且巨噬细胞嗜性谱系常伴vpr缺陷。

要点

  • 原发性NSV由长寿HIV感染巨噬细胞持续产毒所致,不同于CD4+ T细胞克隆机制。
  • 巨噬细胞嗜性HIV基因组在ART期间稳定、不进化,常伴vpr缺陷。
  • 临床需认识此类NSV,治疗优化或强化可能无效。

核心结论

  • 原发性NSV中ART停止病毒复制,但长寿HIV感染巨噬细胞持续产生病毒,机制不同于继发性NSV。

研究设计与样本

  • 研究纳入4例接受ART的晚期免疫缺陷患者,其达到病毒学抑制需约一年或更久。
  • 采集血液样本,对病毒RNA和原病毒DNA基因组测序,分析耐药性、基因组完整性和遗传多样性。
  • 评估HIV Env促进病毒进入低CD4表达细胞的能力,作为巨噬细胞嗜性替代指标。

主要发现

  • ART前血液中的HIV RNA基因组适应CD4+ T细胞复制,ART启动后迅速衰减。
  • ART期间血液中的HIV基因组为药物敏感、遗传多样且具巨噬细胞嗜性,不进化且常伴vpr缺陷。
  • 3例参与者的巨噬细胞嗜性谱系独立累积vpr缺陷,提示vpr可能影响感染巨噬细胞的存活或产毒。

临床怎么用

  • 对ART后出现原发性NSV者,应考虑巨噬细胞持续产毒机制,治疗优化或强化可能无效。

局限性

  • 研究仅纳入4例患者,样本量小。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: HIV-1 RNA typically declines rapidly after initiation of antiretroviral therapy (ART), often reaching undetectable levels within a few weeks and remaining undetectable by standard assays. However, some patients receiving ART have persistent nonsuppressible viremia (NSV) that does not respond to treatment optimization or intensification. NSV can emerge at the time of ART initiation (primary NSV) or after being ART suppressed (secondary NSV). Here, we examine mechanisms producing primary NSV in 4 people undergoing ART. METHODS: Blood samples were collected from 4 participants with advanced immunodeficiency who, despite being adherent to ART, required approximately a year or more to become virologically suppressed. Viral RNA and proviral DNA genomes were sequenced to examine HIV drug resistance, genome intactness, and genetic diversity. The ability of HIV Envs to facilitate efficient entry into cells expressing low levels of CD4, a proxy for macrophage tropism, was also assessed. RESULTS: Before ART, blood contained HIV RNA genomes that were adapted to replication in CD4+ T cells and rapidly decayed after ART initiation. During ART, blood contained HIV genomes that were drug sensitive, genetically diverse, and macrophage tropic; moreover, they were not evolving and often had vpr defects. CONCLUSIONS: Our results suggest that in individuals with primary NSV, ART stopped virus replication, but large pools of long-lived HIV-infected macrophage continued to produce virus. This is mechanistically distinct from secondary NSV produced by CD4+ T-cell clones. Defects in vpr independently accumulated in macrophage-tropic lineages found in 3 participants, suggesting that vpr may affect survival or virus production from HIV-infected macrophage.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Moeser MJ, Council OD, Long N, et al. A New Type of Nonsuppressible Viremia Produced by HIV-Infected Macrophage. J Infect Dis. 2026. PMID: 42018762. doi:10.1093/infdis/jiag171

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。